Skip to content
Screener

BillionToOne, Inc. BLLN EBITDA margin

EBITDA margin at other companies

Labcorp Holdings logo
Labcorp HoldingsLH
15%+1.8pp
Illumina logo
IlluminaILMN
25.5%—
Guardant Health logo
Guardant HealthGH
-37.8%-8.5pp
Natera, Inc. logo
Natera, Inc.NTRA
-8.8%-2.2pp
Personalis, Inc. logo
Personalis, Inc.PSNL
-143.7%-918pp
Myriad Genetics logo
Myriad GeneticsMYGN
-40.7%-53.2pp

Other financials

Income statement

See full
Revenue$109.4M+64.4%
Gross profit$77.1M+77.4%
Operating income$5.5M+438%
Net income$8.1M+3,374%
EPS (diluted)$0.15+850%

Balance sheet

See full
Cash & equivalents$548.6M+190%
Total debt$143.9M—
Total equity$536.8M+315%
Total assets$729.7M—

Cash flow

See full
Operating cash flow$9.1M+673%
CapEx$4.0M+40.9%
Free cash flow$5.1M+401%

Valuation

See full
Market cap$4.32B+0.1%
Enterprise value$3.92B—
P/E114.7×—
P/S10.9×—

Profitability

See full
Gross margin71.3%+10.3pp
Operating margin10.9%+7.0pp
Net margin9.5%+5.9pp
FCF margin8.3%—

Returns & leverage

See full
Return on equity26.3%—
Debt / equity0.3×—
Current ratio11.7×—

Where this comes from

Calculated from BillionToOne, Inc.’s reported figures.

ebitda/total revenue=12.6%

Based on trailing twelve months.

The source filing: BillionToOne, Inc.’s 10-Q, filed August 5, 2026. Open the filing →

Filed
Aug 5, 2026, 4:42 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0002070849-26-000050

FAQ

What is BillionToOne, Inc.'s EBITDA margin?
BillionToOne, Inc. (BLLN) reported EBITDA margin of 12.6% in Q2 2026.
What does EBITDA margin mean?
EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.

Ask your AI about BillionToOne, Inc.'s ebitda margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude